Revised forecast
Fiscal year ending June 2026 · Full yearPrevious forecast published 13 August 2025The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Because the scale of the infectious disease outbreak during the third-quarter accounting period (January to March 2026) was smaller than initially expected, full-year revenue, operating income, ordinary income and net income are expected to fall below the previous forecasts. In the second-quarter accounting period, however, revenue reached a record high for the quarter due to the early influenza outbreak and the continued spread of COVID-19.
| Item | Details |
|---|---|
| Net Sales | ¥20,769 million → ¥15,048 million（-27.6%） |
| Operating profit | ¥8,323 million → ¥4,368 million（-47.5%） |
| Ordinary income | ¥8,143 million → ¥4,127 million（-49.3%） |
| Profit attributable to owners of the parent | ¥8,613 million → ¥5,692 million（-33.9%） |
| Net income per share | 84.66 yen and sen → 54.42 yen and sen |
| Fiscal Period Covered | Fiscal year ending June 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 13 August 2025 |
| Previous-period results | Fiscal year ended June 2025: revenue ¥18,627 million, operating income ¥8,265 million, ordinary income ¥8,219 million, net income ¥6,315 million, and earnings per share of ¥62.07 |
| Reason for the revision | Because the scale of the infectious disease outbreak during the third-quarter accounting period (January to March 2026) was smaller than initially expected, full-year revenue, operating income, ordinary income and net income are expected to fall below the previous forecasts. In the second-quarter accounting period, however, revenue reached a record high for the quarter due to the early influenza outbreak and the continued spread of COVID-19. |
| Dividend forecast revision | No change from the information announced on 14 November 2025 |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Because the scale of the infectious disease outbreak during the third-quarter accounting period was smaller than initially expected, full-year revenue, operating income, ordinary income and net income are expected to fall below the previous forecasts.